Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Veterinary Sciences|June 23, 2022
Bulbus Destruction by Choroidal Melanocytoma in a Dog: A 3-Year HistoryNadine Nautscher, Martin Steffl, Katharina Schmon, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 12, 2013
In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 thresholdWataru Kishimoto, Naoki Ishiguro, Eva Ludwig-Schwellinger, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 17, 2007
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humansStefan Blech, Thomas Ebner, Eva Ludwig-Schwellinger, et al.Journal of Pharmaceutical Sciences|February 13, 2016
Usefulness of A Model-Based Approach for Estimating In Vitro P-Glycoprotein Inhibition Potency in a Transcellular Transport AssayWataru Kishimoto, Naoki Ishiguro, Eva Ludwig-Schwellinger, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 21, 2010
The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humansStefan Blech, Eva Ludwig-Schwellinger, Eva Ulrike Gräfe-Mody, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 12, 2013
Impact of endogenous esterase activity on in vitro p-glycoprotein profiling of dabigatran etexilate in Caco-2 monolayersNaoki Ishiguro, Wataru Kishimoto, Astrid Volz, et al.Chemical Research in Toxicology|December 10, 2014
Sex-, Species-, and Tissue-Specific Metabolism of Empagliflozin in Male Mouse Kidney Forms an Unstable Hemiacetal Metabolite (M466/2) That Degrades to 4-Hydroxycrotonaldehyde, a Reactive and Cytotoxic SpeciesMitchell E Taub, Eva Ludwig-Schwellinger, Naoki Ishiguro, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2011
Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activitiesSumio Ohtsuki, Olaf Schaefer, Hirotaka Kawakami, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2023
Characterization of Enzymes Involved in Nintedanib Metabolism in HumansShimon Nakashima, Rei Sato, Tatsuki Fukami, et al.International Journal of Molecular Medicine|October 18, 2017
Hepatic differentiation of human iPSCs in different 3D models: A comparative studyFlorian Meier, Nora Freyer, Joanna Brzeszczynska, et al.Pageof 1